Abstract
Poly(lactic-co-glycolic acid) (PLGA) particles are one of the most widely used biocompatible and biodegradable materials, and have been extensively investigated as drug delivery vehicles. While a number of different types of additives have been used during and after the synthesis of the PLGA particles for the enhancement of their functions, the shape control of the particles and observations of their shape-dependent properties have been rarely reported to date. To overcome the limitations of conventional PLGA particles, including the slow degradation of PLGA and the resultant slow drug release, we synthesized porous PLGA particles with much higher surface area than in previous works. Unlike in previous studies, the porous PLGA particles in this work exhibit distinctive advantages such as a simpler synthetic scheme, improved size monodispersity, and controllable pore size distribution (approximately 1 μm in diameter). Polyethylenimine (PEI) was chosen as a pore-generating material, which simplified the synthesis process significantly. The performance of the porous PLGA particles was evaluated using doxorubicin (DOX) and the A549 cell line as a drug and target cells of a model system, respectively. Based on the observation of the cell viability, the DOX-loaded porous PLGA particles were determined to be five times more efficient than molecular DOX.
Original language | English |
---|---|
Journal | Bulletin of the Korean Chemical Society |
DOIs | |
Publication status | Published - 2019 Jan 1 |
Fingerprint
Keywords
- Cell viability
- Drug delivery
- Poly(lactic-co-glycolic acid)
- Polyethylenimine
- Porous particle
ASJC Scopus subject areas
- Chemistry(all)
Cite this
One-Pot Synthesis of Highly Monodisperse Poly(lactic-co-glycolic Acid) Particles with Controlled Porosity as Efficient Drug Delivery Vehicles. / Kim, Yoon Hyuck; Byun, Junhyoung; Kim, Byoungjae; Lee, Kijeong; Lee, Jae-Seung; Kim, Tae-Hoon.
In: Bulletin of the Korean Chemical Society, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - One-Pot Synthesis of Highly Monodisperse Poly(lactic-co-glycolic Acid) Particles with Controlled Porosity as Efficient Drug Delivery Vehicles
AU - Kim, Yoon Hyuck
AU - Byun, Junhyoung
AU - Kim, Byoungjae
AU - Lee, Kijeong
AU - Lee, Jae-Seung
AU - Kim, Tae-Hoon
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Poly(lactic-co-glycolic acid) (PLGA) particles are one of the most widely used biocompatible and biodegradable materials, and have been extensively investigated as drug delivery vehicles. While a number of different types of additives have been used during and after the synthesis of the PLGA particles for the enhancement of their functions, the shape control of the particles and observations of their shape-dependent properties have been rarely reported to date. To overcome the limitations of conventional PLGA particles, including the slow degradation of PLGA and the resultant slow drug release, we synthesized porous PLGA particles with much higher surface area than in previous works. Unlike in previous studies, the porous PLGA particles in this work exhibit distinctive advantages such as a simpler synthetic scheme, improved size monodispersity, and controllable pore size distribution (approximately 1 μm in diameter). Polyethylenimine (PEI) was chosen as a pore-generating material, which simplified the synthesis process significantly. The performance of the porous PLGA particles was evaluated using doxorubicin (DOX) and the A549 cell line as a drug and target cells of a model system, respectively. Based on the observation of the cell viability, the DOX-loaded porous PLGA particles were determined to be five times more efficient than molecular DOX.
AB - Poly(lactic-co-glycolic acid) (PLGA) particles are one of the most widely used biocompatible and biodegradable materials, and have been extensively investigated as drug delivery vehicles. While a number of different types of additives have been used during and after the synthesis of the PLGA particles for the enhancement of their functions, the shape control of the particles and observations of their shape-dependent properties have been rarely reported to date. To overcome the limitations of conventional PLGA particles, including the slow degradation of PLGA and the resultant slow drug release, we synthesized porous PLGA particles with much higher surface area than in previous works. Unlike in previous studies, the porous PLGA particles in this work exhibit distinctive advantages such as a simpler synthetic scheme, improved size monodispersity, and controllable pore size distribution (approximately 1 μm in diameter). Polyethylenimine (PEI) was chosen as a pore-generating material, which simplified the synthesis process significantly. The performance of the porous PLGA particles was evaluated using doxorubicin (DOX) and the A549 cell line as a drug and target cells of a model system, respectively. Based on the observation of the cell viability, the DOX-loaded porous PLGA particles were determined to be five times more efficient than molecular DOX.
KW - Cell viability
KW - Drug delivery
KW - Poly(lactic-co-glycolic acid)
KW - Polyethylenimine
KW - Porous particle
UR - http://www.scopus.com/inward/record.url?scp=85068718668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068718668&partnerID=8YFLogxK
U2 - 10.1002/bkcs.11833
DO - 10.1002/bkcs.11833
M3 - Article
AN - SCOPUS:85068718668
JO - Bulletin of the Korean Chemical Society
JF - Bulletin of the Korean Chemical Society
SN - 0253-2964
ER -